TFX vs XGN · P/E 2083, rev $1.12B vs rev $37.2M
Teleflex Incorporated (TFX) versus Exagen Inc (XGN) — a side-by-side from cached financials, not a winner call.
Teleflex Incorporated (TFX) is a medical instruments & supplies company listed on NYSE.
Exagen Inc (XGN) is a diagnostics & research company listed on US.
Latest reported TFX revenue for 2026-06-30 was $1.12B. Net income was $91.5M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
Latest reported XGN revenue for 2026-06-30 was $37.2M. Net income was -$7.2M. XGN currently screens at market cap $154.1M.
TFX currently screens at market cap $5.53B and trailing P/E 2082.7. XGN currently screens at market cap $154.1M.
Not investment advice. Open the TFX and XGN stock pages for the full models.
Not investment advice.